Cibc World Markets Corp Takes Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Cibc World Markets Corp bought a new stake in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) during the 4th quarter, Holdings Channel reports. The fund bought 8,206 shares of the company’s stock, valued at approximately $420,000. Several other hedge funds have also recently made changes to their positions in CRNX. Natixis Advisors LLC […]

Leave a Reply

Your email address will not be published.

Previous post Envestnet Portfolio Solutions Inc. Grows Position in The Hanover Insurance Group, Inc. (NYSE:THG)
Next post Connor Clark & Lunn Investment Management Ltd. Has $353,000 Position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)